Cellebrite - Public Comps and Valuation Multiples

Cellebrite Overview

About Cellebrite

Cellebrite DI Ltd is an Israeli digital intelligence company that provides tools for federal, state, and local law enforcement as well as enterprise companies and service providers to collect, review, analyze, and manage digital data. Some of its products include Cellebrite UFED, Cellebrite Physical Analyzer, Cellebrite UFED Cloud, Cellebrite Frontliner, Cellebrite Responder, Cellebrite Premium, and Cellebrite Seeker.

Founded

1999

HQ

Employees

1.2K+

Website

cellebrite.com

Sectors

Cybersecurity
Public Sector & Non-Profit Software
DefenseTech
B2B SaaS
Vertical SaaS
GovTech

Financials

LTM Revenue $456M

LTM EBITDA $116M

EV

$4.0B

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

Cellebrite Financials

As of September 2025, Cellebrite reported last 12-month revenue of $456M and EBITDA of $116M.

In the same period, Cellebrite generated $386M in LTM gross profit and $12.0M in net income.

See Cellebrite valuation multiples based on analyst estimates

Cellebrite P&L

In the most recent fiscal year, Cellebrite reported revenue of $401M and EBITDA of -$265M.

Cellebrite expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Cellebrite valuation multiples based on analyst estimates

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue	$456M	XXX	$401M	XXX	XXX	XXX
Gross Profit	$386M	XXX	$339M	XXX	XXX	XXX
Gross Margin	85%	XXX	84%	XXX	XXX	XXX
EBITDA	$116M	XXX	-$265M	XXX	XXX	XXX
EBITDA Margin	25%	XXX	-66%	XXX	XXX	XXX
EBIT	$103M	XXX	$56.9M	XXX	XXX	XXX
EBIT Margin	23%	XXX	14%	XXX	XXX	XXX
Net Profit	$12.0M	XXX	-$283M	XXX	XXX	XXX
Net Margin	3%	XXX	-71%	XXX	XXX	XXX
Net Debt	XXX	XXX	n/a	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for Cellebrite including revenue, profitability, and margin analysis across different time periods. The company reported last twelve months revenue of $456M. EBITDA for the last twelve months was $116M. In the most recent fiscal year, Cellebrite achieved $401M in revenue and -$265M in EBITDA.
Financial Metric	Last Twelve Months (LTM)	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2025)	Next Fiscal Year (2026)	Two Years Forward (2027)
Total Revenue	$456M	Analyst estimates available to subscribers	$401M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	$386M	Analyst estimates available to subscribers	$339M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	84.6% gross margin	Analyst estimates available to subscribers	84.4% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	$116M	Analyst estimates available to subscribers	-$265M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	25.4% EBITDA margin	Analyst estimates available to subscribers	-66.1% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	$103M	Analyst estimates available to subscribers	$56.9M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	22.6% EBIT margin	Analyst estimates available to subscribers	14.2% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	$12.0M	Analyst estimates available to subscribers	-$283M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	2.6% net profit margin	Analyst estimates available to subscribers	-70.5% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	Detailed debt information available to subscribers	n/a	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for Cellebrite

This financial data table provides comprehensive performance metrics for Cellebrite, a company based in United States of America. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Recent Performance Highlights

Cellebrite generated $456M in revenue over the last twelve months.
The company achieved $116M in EBITDA over the last twelve months.
Gross profit for the last twelve months was $386M.
Net income over the last twelve months reached $12.0M.

Fiscal Year Performance

In the most recent fiscal year, Cellebrite reported $401M in total revenue.
Fiscal year EBITDA was -$265M.
The company maintained a gross profit margin of 84.4% in the most recent fiscal year.
EBITDA margin for the fiscal year was -66.1%.
Net profit margin reached -70.5% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for Cellebrite. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

Cellebrite Stock Performance

Cellebrite has current market cap of $4.4B, and EV of $4.0B.

Market Cap Evolution

Cellebrite Stock Data

As of October 17, 2025, Cellebrite's stock price is $18.

See Cellebrite trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$4.0B	$4.4B	XXX	XXX	XXX	XXX	$0.01

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Cellebrite Valuation Multiples

Cellebrite's trades at 10.0x EV/Revenue multiple, and -15.1x EV/EBITDA.

See valuation multiples for Cellebrite and 15K+ public comps

Cellebrite Financial Valuation Multiples

As of October 17, 2025, Cellebrite has market cap of $4.4B and EV of $4.0B.

Equity research analysts estimate Cellebrite's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Cellebrite has a P/E ratio of 371.4x.

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Market cap (current)	$4.4B	XXX	$4.4B	XXX	XXX	XXX
EV (current)	$4.0B	XXX	$4.0B	XXX	XXX	XXX
EV/Revenue	8.8x	XXX	10.0x	XXX	XXX	XXX
EV/EBITDA	34.5x	XXX	-15.1x	XXX	XXX	XXX
EV/EBIT	38.7x	XXX	70.2x	XXX	XXX	XXX
EV/Gross Profit	10.4x	XXX	n/a	XXX	XXX	XXX
P/E	371.4x	XXX	-15.7x	XXX	XXX	XXX
EV/FCF	29.0x	XXX	32.9x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Cellebrite Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Cellebrite Margins & Growth Rates

Cellebrite's last 12 month revenue growth is 17%

Cellebrite's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.2M for the same period.

Cellebrite's rule of 40 is -3% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Cellebrite's rule of X is 68% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Cellebrite and other 15K+ public comps

Cellebrite Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue Growth	17%	XXX	17%	XXX	XXX	XXX
EBITDA Margin	25%	XXX	-66%	XXX	XXX	XXX
EBITDA Growth	18%	XXX	n/a	XXX	XXX	XXX
Rule of 40	-3%	XXX	-49%	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	68%	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	$0.3M	XXX	XXX	XXX
Opex per Employee	XXX	XXX	$0.2M	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	33%	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	25%	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	70%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial